Literature DB >> 17195278

Patients with Lewy body dementia use more resources than those with Alzheimer's disease.

Fredrik Boström1, Linus Jönsson, Lennart Minthon, Elisabet Londos.   

Abstract

OBJECTIVES: The purpose of this study was to compare resource use and costs in patients with dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) and to assess determinants of costs of care in DLB.
METHOD: Thirty-four patients with DLB were included in a cross-sectional study. The patients were matched with respect to age, gender and Mini Mental State Examination (MMSE) score to 34 patients with AD. Both groups were examined using Resource Utilisation in Dementia (RUD Lite), MMSE and the Neuropsychiatric inventory (NPI). The DLB patients were additionally examined using the Disability Assessment for Dementia Scale (DAD).
RESULTS: Costs of care in patients suffering from DLB was on average 348,000 SEK (37,500 euro) per year compared to 169,000 SEK (18,200 euro) in the AD group (p < 0.001). Within the DLB group, care costs correlated significantly (r(c) = 2.77, p < 0.001) with dependency in instrumental activities of daily living measured with DAD, whereas MMSE and NPI were not significantly correlated to resource use in the DLB group.
CONCLUSIONS: DLB patients use more resources, and are more costly than AD patients. Dependency in instrumental activities of daily living is strongly correlated to resource use in DLB patients.

Entities:  

Mesh:

Year:  2007        PMID: 17195278     DOI: 10.1002/gps.1738

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  27 in total

1.  The Resource Utilization in Dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia.

Authors:  A Wimo; L Jonsson; A Zbrozek
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Risk of decline in functional activities in dementia with Lewy bodies and Alzheimer disease.

Authors:  Dawn P Gill; Thomas D Koepsell; Rebecca A Hubbard; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

3.  Lewy body dementia: caregiver burden and unmet needs.

Authors:  James E Galvin; John E Duda; Daniel I Kaufer; Carol F Lippa; Angela Taylor; Steven H Zarit
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

4.  The costs of dementia subtypes to California Medicare fee-for-service, 2015.

Authors:  Yingjia Chen; Leslie Wilson; John Kornak; R Adams Dudley; Jennifer Merrilees; Stephen J Bonasera; Christie M Byrne; Kirby Lee; Winston Chiong; Bruce L Miller; Katherine L Possin
Journal:  Alzheimers Dement       Date:  2019-06-04       Impact factor: 21.566

Review 5.  Genetics and underlying pathology of dementia.

Authors:  Beata Ferencz; Lotte Gerritsen
Journal:  Neuropsychol Rev       Date:  2015-01-08       Impact factor: 7.444

Review 6.  Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.

Authors:  Brit Mollenhauer; Hans Förstl; Günther Deuschl; Alexander Storch; Wolfgang Oertel; Claudia Trenkwalder
Journal:  Dtsch Arztebl Int       Date:  2010-10-01       Impact factor: 5.594

7.  Multivariate classification of patients with Alzheimer's and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study.

Authors:  Alexander V Lebedev; E Westman; M K Beyer; M G Kramberger; C Aguilar; Z Pirtosek; D Aarsland
Journal:  J Neurol       Date:  2012-12-08       Impact factor: 4.849

8.  Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies.

Authors:  Nicole Chow; Dag Aarsland; Hedieh Honarpisheh; Mona K Beyer; Johanne H Somme; David Elashoff; Arvid Rongve; Ole B Tysnes; Paul M Thompson; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-20       Impact factor: 2.959

9.  Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Carolyn W Zhu; Nikolaos Scarmeas; Karina Stavitsky; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2008-04-21       Impact factor: 21.566

Review 10.  Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Authors:  Michal Rolinski; Chris Fox; Ian Maidment; Rupert McShane
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.